Stocks and Investing
Stocks and Investing
Fri, October 28, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sarah James Maintained (AMED) at Buy with Decreased Target to $126 on, Oct 28th, 2022
Sarah James of Barclays, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $154 to $126 on, Oct 28th, 2022.
Sarah has made no other calls on AMED in the last 4 months.
There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 2 agree with Sarah's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022
- Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022
These are the ratings of the 3 analyists that currently disagree with Sarah
- Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022
- Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022
Contributing Sources